High-Risk Features Are Prognostic in dMMR/MSI-H Stage II Colon Cancer

ConclusionHigh-risk features are prognostic in the setting of dMMR/MSI-H stage II CC. Adjuvant chemotherapy may improve survival specifically in patients ≥65 years and with high-risk features.
Source: Frontiers in Oncology - Category: Cancer & Oncology Source Type: research